Found: 10
Select item for more details and to access through your institution.
A thorough QT/QTc study of the effect of fasiglifam, a GPR40 agonist, on cardiac repolarization in healthy adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 3, p. 175, doi. 10.1002/cpdd.170
- By:
- Publication type:
- Article
Prolonged Reactive Oxygen Species Generation and Nuclear Factor-κB Activation after a High-Fat, High-Carbohydrate Meal in the Obese.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 11, p. 4476, doi. 10.1210/jc.2007-0778
- By:
- Publication type:
- Article
Low-Dose Rosiglitazone Exerts an Antiinflammatory Effect with an Increase in Adiponectin Independently of Free Fatty Acid Fall and Insulin Sensitization in Obese Type 2 Diabetics.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 9, p. 3553, doi. 10.1210/jc.2005-2609
- By:
- Publication type:
- Article
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1324, doi. 10.1002/ejhf.3253
- By:
- Publication type:
- Article
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of the GPR40 Agonist TAK-875: Results From a Double-Blind, Placebo-Controlled Single Oral Dose Rising Study in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 7, p. 1007, doi. 10.1177/0091270011409230
- By:
- Publication type:
- Article
Low Concentration of Prostate Specific Antigen in Patients with Hypogonadotrophic Hypogonadism in Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A558
- By:
- Publication type:
- Article
Retinol Binding Protein-4 Between in Lean, Obese and Type 2 Diabetic Subjects: Lack of Effect of Caloric Restriction and Rosiglitazone.
- Published in:
- Diabetes, 2007, v. 56, p. A469
- By:
- Publication type:
- Article
Absence of Oxidative and Inflammatory Response Following Orange Juice: A Comparison with Glucose Intake.
- Published in:
- Diabetes, 2007, v. 56, p. A449
- By:
- Publication type:
- Article
Olmesartan, an Angiotensin II Receptor Blocker, Suppresses Oxidative Stress and Inflammation in Patients with Coronary Artery Disease or Risk Factors for Atherosclerosis.
- Published in:
- Diabetes, 2007, v. 56, p. A161
- By:
- Publication type:
- Article
Differential Effects of Cream, Glucose, and Orange Juice on Inflammation, Endotoxin, and the Expression of Toll-Like Receptor-4 and Suppressor of Cytokine Signaling-3.
- Published in:
- Diabetes Care, 2010, v. 33, n. 5, p. 991, doi. 10.2337/dc09-1630
- By:
- Publication type:
- Article